Earnings Call · Q1 FY2023·2023-05-11

Q1 23EPS -52.78%·Rev n/aQ4 22EPS +24.39%·Rev n/aQ3 22EPS +35.29%·Rev n/aQ2 22EPS +38.60%·Rev n/a⚠ consensus missing

AVITA Medical, Inc. RCEL

Jessica Ekeberg — Investor Relations

James Corbett — CEO

Sean Ekins — CFO

−1.9%1d on move date−1.8% vs SPY3d−21.1%5d−24.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RCEL calls or request research access.

More RCEL calls Browse calls Request research access